Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2020

Dec 21, 2020

29841_dirs_2020-12-21_9d8b9fa5-1053-4f82-b3c8-97d17132c813.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-12-16

Reporting Person: WHITE ROBERT JOHN (EVP & Pres. Medical Surgical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-16 Ordinary Shares G 1500 Disposed 55852 Direct
2020-12-16 Ordinary Shares G 1500 Acquired 1500 Indirect
2020-12-18 Ordinary Shares S 10930 $115.46 Disposed 44922 Direct

Footnotes

F1: These securities are owned by the White Family Legacy Trust. The reporting person is the co-trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.43 to $115.52, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.